Spots Global Cancer Trial Database for Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer
Official Title: Multicenter, Prospective Phase-I/II-study: Topotecan and Carboplatin in the Therapy of Patients With Relapsed Ovarian Cancer
Study ID: NCT00170625
Conditions
Interventions
Study Description
Brief Summary: Compatibility of the topotecan therapy in combination with carboplatin.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Jalid Sehouli
Affiliation: Charite University, Berlin, Germany
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
